Insulin-dependent attenuation in α2-adrenoreceptor-mediated nociception in experimental diabetes

Pharmacology Biochemistry and Behavior

Volumn 56, Issue 1, 1996, Pages 15-20

  Bitar, Milad S ^a   Pilcher, Charles William Thomas ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

clonidine; experimental diabetes; insulin; nociception; yohimbine

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; INSULIN; YOHIMBINE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; NOCICEPTION; NONHUMAN; NORADRENERGIC SYSTEM; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; SUBCUTANEOUS DRUG ADMINISTRATION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CLONIDINE; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HYPOGLYCEMIC AGENTS; INSULIN; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; YOHIMBINE;

EID: 0031012643     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00129-3     Document Type: Article

References (39)

1. Akunne H., Soliman K. F. The role of opioid receptors in diabetes and hyperglycemia-induced changes in pain threshold in the rat. Psychopharmacology (Berlin). 93:1987;167-172.
2. Bitar M. S., DeSouza E. B. Diabetes-related changes in brain beta adrenoreceptors in rats as assessed by quantitative autoradiography. Relationship to hypothalamic norepinephrine metabolism and pituitary gonadal hormone secretion J . Pharmacol. Exp. Ther. 254:1990;781-785.
3. Bitar M. S., Keis A. F., Owusu S. E., Mulven R., DeSouza E. B. Impairment of albuterol-induced suppression of food intake in diabetes mellitus. Pharmacol. Biochem. Behav. 41:1992;483-487.
4. Bitar M. S., Koulu M., Rapoport S. I., Linnoila M. Diabetes-induced alterations in brain monoamine metabolism in rats. J. Pharmacol. Exp. Ther. 236:1986;432-437.
5. Bitar M. S., Weiner M. Diabetes-induced metabolic alterations in heme and various heme-containing enzymes in female rats. Diabetes. 33:1984;37-44.
6. Bitar M. S., Weiner M. Heme and hemoproteins in streptozotocin diabetic female rats. Biochem. Pharmacol. 32:1983;1921-1928.
7. Bonnet F., Brun-Buisson V., Francois Y., Catoire P., Saada M. Effects of oral and subarachnoid clonidine on spinal anaesthesia with bupivacaine. Reg. Anaesth. 15:1990;211-214.
8. Danzebrink R. M., Gebhart G. F. Antinociceptive effects of intrathecal adrenoreceptor agonists in a rat model of visceral nociception. J. Pharmacol. Exp. Ther. 253:1990;698-705.
9. Davis K. D., Treede K. D., Raja S. N., Meyer R. A., Campbell J. N. Topical application of clonidine relieves hyperalgesia in patients with sympathetically maintained pain. Pain. 47:1991;309-318.
10. Eisenach J. C., Rauck R. L., Buzzenell C., Lysak S. Z. Epidural clonidine analgesia for intractable cancer pain. Phase I Anaesthesiology. 71:1989;647-652.
11. Feteris W. A. A serum glucose method without protein precipitation. Am. J. Med. Technol. 31:1965;17-21.
12. Franz D. N., Hare B. D., McCloskey K. L. Spinal sympathetic neurons. Possible site of opiates-withdrawal suppression by clonidine Science. 215:1982;1643-1643.
13. Glynn C., Dawson D., Sanders R. A double-blind comparison between epidural morphine and epidural clonidine in patients with chronic noncancer pain. Pain. 34:1988;123-128.
14. 2 adrenergic action in diabetic rats. Pharmacol. Biochem. Behav. 39:1991;383-387.
15. Janssen P. A. J., Niemegeers C., Dony J. The inhibitory effects of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawal reflex in rats. Arzneimittelforschung. 13:1963;502-507.
16. Junod A., Lambert A. E., Orci L., Pictet R., Gomet A. S., Renold A. E. Studies of the diabetogenic action of streptozotocin. Proc. Soc. Exp. Biol. Med. 126:1969;201-205.
17. Junod A., Lambert A. E., Stauffacher W, Renold A. E. Diabetogenic action of streptozotocin. Relationship of dose to metabolic response J. Clin. Invest. 48:1969;2129-2139.
18. Kato R. Drug metabolism under pathologic and abnormal physiological states in animals and man. Xenobiotics. 7:1977;25-92.
19. Koukinen S., Pyykko K. The potentiation of halothane anaesthesia by clonidine. Acta Anaesthesiol. Scand. 23:1979;107-111.
20. Lackovic Z., Salkovic M., Kuci Z., Relja M. Effect of long-lasting diabetes mellitus on rat and human brain monoamines. J. Neurochem. 54:1990;143-147.
21. 2-adrenoreceptor agonists. Pharmacol. Commun. 6(Suppl):1995;175-182.
22. 2-adrenoreceptor agonists in rats. Anaesthesiology. 81:1994;677-688.
23. Mendez R., Eisenach J. C., Kashtan K. Epidural clonidine analgesia after caesarian section. Anaesthesiology. 73:1990;848-852.
24. 2 adrenergic receptors in the control of nociception, motor behaviour and hippocampal synthesis of noradrenaline. J. Pharmacol. Exp. Ther. 270:1994;958-972.
25. Monasky M. S., Zinsmeister A. R., Stevens C. W., Yaksh T. L. Interaction of intrathecal morphine and ST91 on antinociception in the rat. Dose-response analysis, antagonism and clearance J. Pharmacol. Exp. Ther. 254:1990;383-392.
26. Morley G. K., Mooradian A. D., Levine A. S., Morely J. E. Mechanism of pain in diabetic peripheral neuropathy. The effect of glucose on pain perception in humans Am. J. Med. 77:1984;79-83.
27. Nakamura M., Ferreira S. H. Peripheral analgesic action of clonidine. Mediation by release of endogenous enkephalin-like substances Eur. J. Pharmacol. 146:1988;223-228.
28. Ossipov M. H., Harris S., Lloyd P., Messineo E. An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates. J. Pharmacol. Exp. Ther. 255:1990;1107-1116.
29. Paalzow G. H. M., Paalzow L. K. Yohimbine both increases and decreases nociceptive threshold in rats. Evaluation of the dose-response relationship Naunyn-Schmied. Pharmacol. 332:1983;193-197.
30. Proudfit H. K. Pharmacological evidence for the modulation of nociception by noradrenergic neurons. Prog. Brain Res. 77:1988;357-370.
31. Roy M., Collier B., Roy A. Hypothalamic-pituitary adrenal axis dysregulation among diabetic and out-patients. Psych. Res. 31:1990;31-37.
32. Simon G. S., Borzelleca J., Dewey W. L. Narcotic and diabetes. II. Streptozotocin-induced diabetes selectively alters the potency of narcotic analgesics. Mechanism of diabetes. Morphine interaction J. Pharmacol. Exp. Ther. 218:1981;324-329.
33. Simon G. S., Dewey W. L. Narcotic and diabetes. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine. J. Pharmacol. Exp. Ther. 218:1981;318-323.
34. 2-agonists and antagonists in rats. J. Pharmacol. Exp. Ther. 261:1992;764-772.
35. 2-agonist-binding sites in the rat and human CNS. Analysis of some functional anatomic correlates of the pharmacological effects of clonidine and related adrenergic agents Brain Res. Rev. 319:1984;69-101.
36. Yaksh T. L. Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing. Pharmacol. Biochem. Behav. 22:1985;845-858.
37. Yaksh T. L., Rudy T. A. Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 17:1976;1031-1036.
38. Zeigler D., Lynch S. A., Muir J., Benjamin J., Max M. B. Transdermal clonidine vs. placebo in painful diabetic neuropathy. Pain. 48:1992;403-408.
39. Zhang P. L., Patel K. P. Blunted diuretic and natriuretic responses to central administration of clonidine in streptozotocin-induced diabetic rats. Diabetes. 40:1991;338-343.